Characteristics of Dopaminergic Neurotoxicity Produced by MPTP and Methamphetamine

This publication has 24 references indexed in Scilit:

• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Metabolism and l-Methyl-4-Phenylpyridinium Uptake in Dissociated Cell Cultures from the Embryonic Mesencephalon
  Journal of Neurochemistry, 1988
• Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+
  Neuroscience Letters, 1987
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes
  Biochemical and Biophysical Research Communications, 1986
• Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources
  European Journal of Pharmacology, 1985
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
  Proceedings of the National Academy of Sciences, 1985
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
  Nature, 1984
• Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
  Science, 1984
• Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.
  Proceedings of the National Academy of Sciences, 1982